Skip to content

The effect of fortified biscuit with vitamin D on deficient children

the effect of fortified biscuit with vitamin D, versus oral and injectable methods for treatment of children with vitamin D deficiency aged 30 to 72 month

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201504296705N3
Enrollment
150
Registered
2015-08-05
Start date
2015-05-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin D deficiency. Vitamin D deficiency, unspecified

Interventions

Intervention 1: The intervention group: A fortified biscuit with 200000 units vitamin D powder manufactured by Roche Germany, three times during a day only for one week. Duration of study is one year
Treatment - Other
Treatment - Drugs
The intervention group: A fortified biscuit with 200000 units vitamin D powder manufactured by Roche Germany, three times during a day only for one week. Duration of study is one year.
The first control group 1: Injection two vial of 300000 units vitamin D manufactured by Osve company, single dose. Duration of study is one year.
The second control group: Oral administration of two capsules of 50,000 units produced by Dana company every 12 hours during a day for three times in only a week. Duration of study is one year.

Sponsors

Vice chancellor for research Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 6 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Good general health and age between 30 and 72 months Exclusion criteria: Chronic liver and renal diseases; regular use of vitamin D supplements during the past 3 months

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
25-OH vitamin D. Timepoint: before and at least two weeks after the end of treatment. Method of measurement: Elisa method.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLeila Moslemi

Amirkola Children’s Hospital

moslemi.iausari@gmail.com+98 11 3234 6963

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026